180 related articles for article (PubMed ID: 16781110)
1. Progress in the development of childhood cancer therapy.
Garolla A; Pizzato C; Ferlin A; Carli MO; Selice R; Foresta C
Reprod Toxicol; 2006 Aug; 22(2):126-32. PubMed ID: 16781110
[TBL] [Abstract][Full Text] [Related]
2. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
[TBL] [Abstract][Full Text] [Related]
3. Does ifosfamide affect gonadal function?
Williams D; Crofton PM; Levitt G
Pediatr Blood Cancer; 2008 Feb; 50(2):347-51. PubMed ID: 17973323
[TBL] [Abstract][Full Text] [Related]
4. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
[TBL] [Abstract][Full Text] [Related]
5. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
6. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood.
Kenney LB; Laufer MR; Grant FD; Grier H; Diller L
Cancer; 2001 Feb; 91(3):613-21. PubMed ID: 11169946
[TBL] [Abstract][Full Text] [Related]
7. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility.
Nurmio M; Keros V; Lähteenmäki P; Salmi T; Kallajoki M; Jahnukainen K
J Clin Endocrinol Metab; 2009 Jun; 94(6):2119-22. PubMed ID: 19318447
[TBL] [Abstract][Full Text] [Related]
8. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.
Skinner R; Cotterill SJ; Stevens MC
Br J Cancer; 2000 May; 82(10):1636-45. PubMed ID: 10817497
[TBL] [Abstract][Full Text] [Related]
10. Growth impairment after ifosfamide-induced nephrotoxicity in children.
Stöhr W; Patzer L; Paulides M; Kremers A; Beck JD; Langer T; Rossi R
Pediatr Blood Cancer; 2007 May; 48(5):571-6. PubMed ID: 16755549
[TBL] [Abstract][Full Text] [Related]
11. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.
Green DM; Liu W; Kutteh WH; Ke RW; Shelton KC; Sklar CA; Chemaitilly W; Pui CH; Klosky JL; Spunt SL; Metzger ML; Srivastava D; Ness KK; Robison LL; Hudson MM
Lancet Oncol; 2014 Oct; 15(11):1215-23. PubMed ID: 25239573
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity during ifosfamide treatment in children.
Di Cataldo A; Astuto M; Rizzo G; Bertuna G; Russo G; Incorpora G
Med Sci Monit; 2009 Jan; 15(1):CS22-5. PubMed ID: 19114973
[TBL] [Abstract][Full Text] [Related]
13. Spermatogenesis after cancer treatment: damage and recovery.
Howell SJ; Shalet SM
J Natl Cancer Inst Monogr; 2005; (34):12-7. PubMed ID: 15784814
[TBL] [Abstract][Full Text] [Related]
14. Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase.
Medrano JV; Hervás D; Vilanova-Pérez T; Navarro-Gomezlechon A; Goossens E; Pellicer A; Andrés MM; Novella-Maestre E
Reprod Sci; 2021 Feb; 28(2):603-613. PubMed ID: 33150486
[TBL] [Abstract][Full Text] [Related]
15. Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
Volm T; Pfaff P; Gnann R; Kreienberg R
Gynecol Oncol; 2001 Jul; 82(1):197-9. PubMed ID: 11426986
[TBL] [Abstract][Full Text] [Related]
16. Gonadal dysfunction and fertility problems in cancer survivors.
Brydøy M; Fosså SD; Dahl O; Bjøro T
Acta Oncol; 2007; 46(4):480-9. PubMed ID: 17497315
[TBL] [Abstract][Full Text] [Related]
17. [Gonadal function after cancer treatment in adult men].
Kiserud CE; Magelssen H; Fedorcsak P; Fosså SD
Tidsskr Nor Laegeforen; 2008 Feb; 128(4):461-5. PubMed ID: 18274582
[TBL] [Abstract][Full Text] [Related]
18. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
[TBL] [Abstract][Full Text] [Related]
19. Dacarbazine induces genotoxic and cytotoxic germ cell damage with concomitant decrease in testosterone and increase in lactate dehydrogenase concentration in the testis.
Kumar SG; Narayana K; Bairy KL; D'Souza UJ; Samuel VP; Gopalakrishna K
Mutat Res; 2006 Sep; 607(2):240-52. PubMed ID: 16793327
[TBL] [Abstract][Full Text] [Related]
20. Gonadal function and pubertal development after treatment of a childhood malignancy.
Cicognani A; Pasini A; Pession A; Pirazzoli P; Burnelli R; Barbieri E; Mazzanti L; Cacciari E
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():321-6. PubMed ID: 12729411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
